Topical co-delivery of platelet rich fibrin and tranexamic acid does not decrease blood loss in primary total knee arthroplasty compared to the standard of care: a prospective, randomized, controlled trial

被引:6
|
作者
Tandogan, Reha N. [1 ]
Polat, Metin [1 ]
Beyzadeoglu, Tahsin [2 ,3 ]
Karabulut, Erdem [4 ]
Yildirim, Kerem [3 ,5 ]
Kayaalp, Asim [1 ]
机构
[1] Ortoklin & Cankaya Orthoped, Cinnah Caddesi 51-4, TR-06680 Ankara, Turkey
[2] Halic Univ, Orthopaed & Traumatol, Bagdat Cad 333 Erenkoy, TR-34738 Istanbul, Turkey
[3] Beyzadeoglu Clin, Bagdat Cad 333 Erenkoy, TR-34738 Istanbul, Turkey
[4] Hacettepe Univ, Dept Biostat, Sihhiye Campus, Ankara, Turkey
[5] Istanbul Gelisim Univ, Orthopaed & Traumatol, Bagdat Cad 333 Erenkoy, TR-34738 Istanbul, Turkey
关键词
Platelet rich fibrin; Tranexamic acid; Total knee arthroplasty; Blood loss; TOURNIQUET USE; MANAGEMENT STRATEGIES; CLINICAL-TRIAL; METAANALYSIS; TRANSFUSION; SUPERIOR; EFFICACY; SEALANT; HIP;
D O I
10.1007/s00167-020-05938-1
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Purpose The purpose of this study was to evaluate the efficacy of intra-operative co-administration of tranexamic acid (TA) and platelet rich fibrin (PRF) using a proprietary co-delivery system on the amount of blood loss, early functional outcomes and wound complications after primary total knee arthroplasty (TKA). The intervention was compared to the standard of care (combined intravenous & topical TA) in a prospective, randomized, blinded setting. Methods 80 patients undergoing primary cemented TKA without tourniquet were prospectively randomized into control (combined intravenous and topical TA) and PRF (intra-venous TA and co-delivery of topical PRF and TA) groups after informed consent. Total blood loss, drainage blood loss, knee range of motion, VAS pain scores, length of stay and wound complications were analysed. Data collection was performed in a double blind manner on days 1, 3 and 21. Results There was no statistically significant difference in drainage blood loss (550 ml vs. 525 ml,p = 0.643), calculated total blood loss on day 1 (401 ml vs. 407 ml,p = 0.722), day 3 (467 ml vs 471 ml,p = 0.471) and day 21 (265 ml vs. 219 ml,p = 0.082) between the PRF and control groups respectively. The PRF group had a small but statistically significant increase in median knee extension in the early post-operative period, however this difference evened out at 3 weeks. No significant difference could be demonstrated between the PRF and control groups in length of stay, VAS pain scores, narcotic usage, wound complications and knee flexion at all time points. Conclusions The topical co-delivery of PRF and TA does not significantly decrease blood loss in primary TKA compared to the standard of care. Slightly better active knee extension in the first 3 postoperative days can be achieved, however this benefit is not clinically relevant.
引用
收藏
页码:519 / 528
页数:10
相关论文
共 50 条
  • [41] Combined Administration of Systemic and Topical Tranexamic Acid for Total Knee Arthroplasty: Can It Be a Better Regimen and Yet Safe? A Randomized Controlled Trial
    Jain, Nimesh P.
    Nisthane, Prithviraj P.
    Shah, Nilen A.
    JOURNAL OF ARTHROPLASTY, 2016, 31 (02) : 542 - 547
  • [42] The efficacy and safety of multiple-dose intravenous tranexamic acid on blood loss following total knee arthroplasty: a randomized controlled trial
    Yiting Lei
    Jinwei Xie
    Bin Xu
    Xiaowei Xie
    Qiang Huang
    Fuxing Pei
    International Orthopaedics, 2017, 41 : 2053 - 2059
  • [43] Blood Loss and Transfusion After Topical Tranexamic Acid Administration in Primary Total Knee Arthroplasty
    Wang, Hao
    Shen, Bin
    Zeng, Yi
    ORTHOPEDICS, 2015, 38 (11) : E1007 - E1016
  • [44] Effect of tranexamic acid on blood loss after reverse total shoulder arthroplasty according to the administration method: a prospective, multicenter, randomized, controlled study
    Yoon, Ji Young
    Park, Joo Hyun
    Kim, Yang Soo
    Shin, Sang Jin
    Yoo, Jae Chul
    Oh, Joo Han
    JOURNAL OF SHOULDER AND ELBOW SURGERY, 2020, 29 (06) : 1087 - 1095
  • [45] Efficacy of oral tranexamic acid on blood loss in primary total hip arthroplasty using a direct anterior approach: a prospective randomized controlled trial
    HaiYan Zhao
    MaoYing Xiang
    YaYi Xia
    Xiaojun Shi
    Fu-Xing Pei
    PengDe Kang
    International Orthopaedics, 2018, 42 : 2535 - 2542
  • [46] Tranexamic acid reduces blood loss in simultaneous bilateral total knee arthroplasty: a randomized control trial
    A. Raviraj
    Ashish Anand
    Murali Chakravarthy
    S. Kumarswamy
    Ajith Prabhu
    Sanjay Pai
    European Journal of Orthopaedic Surgery & Traumatology, 2012, 22 : 381 - 386
  • [47] Topical vs Intravenous Tranexamic Acid in Primary Total Hip Arthroplasty: A Double-Blind, Randomized Controlled Trial
    North, Wayne T.
    Mehran, Nima
    Davis, Jason J.
    Silverton, Craig D.
    Weir, Robb M.
    Laker, Michael W.
    JOURNAL OF ARTHROPLASTY, 2016, 31 (05) : 1022 - 1026
  • [48] Tranexamic acid in primary total knee arthroplasty without tourniquet: a randomized, controlled trial of oral versus intravenous versus topical administration
    Wang, Duan
    Wang, Hao-Yang
    Cao, Chang
    Li, Ling-Li
    Meng, Wei-Kun
    Pei, Fu-Xing
    Li, De-Hua
    Zhou, Zong-Ke
    Zeng, Wei-Nan
    SCIENTIFIC REPORTS, 2018, 8
  • [49] Topical tranexamic acid in cemented primary total knee arthroplasty without tourniquet: a prospective randomized study
    Manuel Morales Santias
    Jesus Mas Martinez
    Javier Sanz-Reig
    Enrique Martínez Gimenez
    Carmen Verdu Román
    David Bustamante Suarez de Puga
    European Journal of Orthopaedic Surgery & Traumatology, 2020, 30 : 1003 - 1008
  • [50] Effect of Multiple Doses of Intravenous Tranexamic Acid on Perioperative Blood Loss in Total Knee Arthroplasty: A Randomized Controlled Study
    Kang, Bing-xin
    Li, Yu-lin
    Xu, Hui
    Gao, Chen-xin
    Zhong, Sheng
    Zhang, Jing
    Xie, Jun
    Sun, Song-tao
    Xu, Xi-rui
    Zhao, Chi
    Ma, Ying-hui
    Zhai, Wei-tao
    Xiao, Lian-bo
    Hu, Xiao-xue
    ORTHOPAEDIC SURGERY, 2021, 13 (01) : 126 - 133